The United States government has discontinued its free at-home COVID-19 test program after four years. The program, which ...
for its next-gen molecular Metrix® COVID/Flu multiplex test. This innovative test represents a major advancement in accessible molecular diagnostics. The Metrix® COVID/Flu test simultaneously ...
Q4 2024 Management View CEO Dwight Egan highlighted the development advancements of the Co-Dx PCR testing platform, including its low-cost, rapid, and easy-to-use features. The company withdrew its ...
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Aptitude Medical Systems’ Metrix Covid/Flu multiplex test for over-the-counter (OTC) use. The decision ...